Daewoong Pharmaceutical Co., Ltd (KRX:069620)
121,900
+3,000 (2.52%)
At close: Jul 16, 2026
Daewoong Pharmaceutical Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Daewoong Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩207,778. The average 1-year stock price forecast is 70.45% higher than the current stock price, while the lowest is ₩200,000 (+64.07%) and the highest is ₩220,000 (+80.48%).
Price Target: ₩207,778 (+70.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Daewoong Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 5 | 4 | 4 |
| Buy | 5 | 5 | 5 | 6 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 11 | 9 | 9 |
Financial Forecast
Revenue This Year
1.66T
from 1.57T
Increased by 5.82%
Revenue Next Year
1.77T
from 1.66T
Increased by 6.54%
EPS This Year
17.32K
from 14.45K
Increased by 19.88%
EPS Next Year
17.59K
from 17.32K
Increased by 1.56%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.